Leading animal health company Medgene has been granted a second license by the USDA Center for Veterinary Biologics (CVB) to produce and market a groundbreaking Platform Vaccine for the pork industry. This USDA-approved license allows Medgene to leverage their Platform technology and develop vaccines addressing critical diseases in pigs, including Rotavirus, Porcine Circovirus, Influenza A, and Sapovirus.
Medgene's vaccine approach is built on a revolutionary "platform technology" that offers safety and adaptability for addressing multiple animal disease targets. By employing this technology, Medgene can rapidly develop vaccines and gain insights into the transmission of diseases across species and geographies, significantly reducing the time required compared to traditional vaccine development approaches.
Dr. Clayton Johnson, Director of Veterinary Services for Carthage Veterinary Service, LTD, lauded Medgene's Platform Vaccines, emphasizing how they enable the maintenance of high animal health standards.
The announcement of Medgene's licensure took place on June 8 at the World Pork Expo held in Des Moines, Iowa. Mark Luecke, CEO of Medgene, expressed the significance of the pork industry to the nation's food supply and highlighted the company's long-standing efforts to make the power of Platform technology accessible to pork industry veterinarians. With the license, Medgene can now provide the industry with safe, efficient, and cost-effective vaccine solutions.
Licensed veterinarians can now access Medgene's innovative vaccines for Rotavirus, Porcine Circovirus, Influenza A, and Sapovirus. These vaccines promise to revolutionize disease prevention and management within the pork industry, safeguarding animal health and enhancing the overall productivity and sustainability of pork production.
Source : pennsylvaniaagconnection